Washington, DC--
On his first day in office, President Trump signed a Memorandum on "American First Trade Policy" which is a broad directive to all the Administration's principal trade officials to review many aspects of U.S. trade policy and report back to him by April 1, 2025.
Among the provisions is section 2(i) directing officials to "shall assess the loss of tariff revenues and the risks from importing counterfeit products and contraband drugs, e.g., fentanyl, that each result from the current implementation of the $800 or less, duty-free de minimis exemption under section 1321 of title 19, United States Code, and shall recommend modifications as warranted to protect both the revenue of the United States and the public health by preventing unlawful importations."
Read the Memorandum here
